UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 15, 2015
Accession Number:
0001193125-15-131375
Submission Type:
POS AM
CIK:
0001069308
Company Name:
Opexa Therapeutics, Inc.
File Number:
333-201731